Webinars and Sponsored Roundtables — Register Now

Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.

Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.

Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.

Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

CAP Today Recommends

Orchard white paper focuses on value of labs

Orchard Software has published a free white paper entitled, “The Value of the Lab in the New Healthcare Model.” If you are concerned about how your laboratory will fit in the changing health care environment, this white paper can help you rethink your lab’s role within your organization, encourage you to become more engaged in your facility’s overall success, and help you successfully maneuver through the volume-to-value shift in the health care reimbursement model. * More CAP TODAY Recommends *

CAP offers comment period on IHC guideline

The College of American Pathologists Pathology and Laboratory Quality Center (the Center) develops and maintains evidence-based guidelines and consensus statements. The CAP welcomes participation in the open comment period through July 29, on the Center guideline recommendations for Immunohistochemical (IHC) Assays: Principles of Analytic Validation. IHC testing is an essential component of the pathologic evaluation of many specimens and increasingly provides key information that helps determine how patients are treated. As with any laboratory test, laboratories must validate all IHC assays

Clarient Continuum Webinar Series

As part of its Continuum series, Clarient offers the free webinar “Enhancing Flow Cytometry Service,” which takes place on both Tuesday, June 4, and Thursday, June 13. Antony Bakke, PhD (ABMLI), director of flow cytometry, Clarient, will present the webinar, the focus of which will be a 10-color assay that improves sensitivity to detect hematopoietic neoplasia. [more] * More CAP TODAY Recommends * *

CAP, others offer input about pricing for molecular tests

A coalition representing more than 120,000 medical and laboratory professionals and institutions that perform the vast majority of clinical molecular pathology testing in the United States released a joint statement about new Medicare prices for those tests. The groups include the CAP, American Association for Clinical Chemistry, American Clinical Laboratory Association, American College of Medical Genetics and Genomics, American Society for Clinical Pathology, American Society for Histocompatibility and Immunogenetics, Association for Molecular Pathology, California Clinical Laboratory Association, and Society for

CAP releases a new evidence-based guideline

Validating Whole Slide Imaging for Diagnostic Purposes in Pathology This clinical guideline, now available in Archives of Pathology & Laboratory Medicine, is the first-of-its kind and marks a significant step forward in demonstrating the value of this emerging technology for diagnostic use. The document serves as a practical guide for pathologists and laboratories to confirm the accuracy and concordance of their own whole slide imaging (WSI) systems for diagnostic work while ensuring the digital tool is being used properly for

The Artel Digest: Liquid Handling QA Newsletter

The Artel Digest contains timely information, regulatory updates, application notes, and news about best practices in pipetting and automated liquid handling. [more] * More CAP TODAY Recommends * *

Roundtable discussions 2013: The future of the lab in health care

Video Series In a collaborative effort to discuss the future of the laboratory in health care, CAP TODAY publisher Bob McGonnagle met with Orchard Software chief operating officer Curt Johnson and Orchard medical director Mick Glant, MD. This series of “roundtable discussions” was recorded and edited into a series of short videos on various topics surrounding the laboratory and informatics. We’ve published a total of eight videos, which you can watch here.

Pⁿ Blog: How common are occult specimen mixups?

We have all encountered aberrant bits of tissue (floaters) on microscopic slides and within paraffin tissue blocks. Most of the time these are from obviously different tissue types and pose no diagnostic difficulty, though they often serve for us to remind the gross room and histopathology staff of the importance of scrupulous cleanliness. [more]   More CAP TODAY Recommends    

CAP offers white paper on lab interoperability

The College of American Pathologists has released a white paper, “Laboratory Interoperability Best Practices.” The CAP Diagnostic Intelligence and Health Information Technology (DIHIT) Committee developed the paper to provide pathologists and laboratory professionals with a concise overview of 10 common issues to consider when establishing and maintaining laboratory interfaces, along with approaches for issue mitigation.   More CAP TODAY Recommends    

Clarient offers educational webinars

Clarient has launched its Continuum Webinar Educational Series. Each 30-minute presentation enables participants to hear specialists, gain insights, and learn about industry innovations. The series features a distinguished panel of experts on different topics, which you can find out about and register for here.   More CAP TODAY Recommends